Iron Deficiency Anaemia in Pregnant Patients Presenting for Antenatal Care
Sponsor
University of Cape Town (Other)
Overall Status
Completed
CT.gov ID
NCT05157828
Collaborator
(none)
132
1
4
1004.4
Study Details
Study Description
Brief Summary
This is a cross-sectional, prospective study of iron deficiency anaemia among pregnant patients presenting for antenatal care at a secondary level institution in the Western Cape, Mowbray Maternity Hospital, over a one-week period.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
132 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
A Cross-sectional Prospective Study of the Prevalence of Iron Deficiency Anaemia in Pregnant Patients Presenting for Antenatal Care at a Secondary Level Institution, Mowbray Maternity Hospital
Actual Study Start Date
:
Jan 31, 2022
Actual Primary Completion Date
:
Feb 4, 2022
Actual Study Completion Date
:
Feb 4, 2022
Outcome Measures
Primary Outcome Measures
- Prevalence of anaemia among all women presenting for antenatal care at a secondary level institution in the Western Cape, Mowbray Maternity Hospital, during a one-week period. [One week]
Proportion
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
All women presenting to the antenatal care services at Mowbray Maternity Hospital over the period of study recruitment.
-
≥ 18 years of age.
-
Screen as anaemic (World Health Organisation <11g/dl) on bedside finger-prick haemoglobin.
-
Who consent to participate.
Exclusion Criteria:
Patients who refuse to participate, and those under the age of 18 years will be excluded from the study.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Mowbray maternity hospital | Cape Town | Western Cape | South Africa | 7700 |
Sponsors and Collaborators
- University of Cape Town
Investigators
- Principal Investigator: Christella Alphonsus, MBChB, University of Cape Town
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Christella Alphonsus,
Principal investigator,
University of Cape Town
ClinicalTrials.gov Identifier:
NCT05157828
Other Study ID Numbers:
- UCape Town
First Posted:
Dec 15, 2021
Last Update Posted:
May 18, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: